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Abstract 
 Background: The pandemicity of  the human immunodeficiency virus 
(HIV) has continued  to be a ‘medical quagmire,’ one of the most serious 
global catastrophe and  public health problem that plagues the  world today. 
Objectives: To determine the seroprevalence and  clinico-epidemiological 
correlates of  HIV infection  in pregnancy. Methodology: This is a descriptive 
cross sectional study. Two hundred and twenty (220) consecutive healthy 
pregnant women attending the antenatal booking clinic of  the  hospital who 
met the inclusion criteria were recruited. Data was collected via a 
questionnaire. Data entry and analysis was done using SPSS (statistical 
package for social sciences) 22 statistical package (SPSS Inc., Illinois, U.S.A). 
P value less than 0.05 was taken as being significant. Results: Of the 220 
women, 4.6% (n=10) were seropositive for HIV antibodies. Multiple sexual 
partners was the significant risk factors for HIV seropositivity (p<0.05). There 
was no significant association with respect to tattoo/scarification marks, 
female circumcision,  previous blood transfusion, intravenous drug abuse or 
sharing of sharps, previous surgery, episiotomies or dilatation and curettage 
(p>0.05). Conclusion: The high endemicity of HIV  infection in this study 
justifies the need for routine screening in pregnancy to identify and institute 
treatment of the infection promptly as this will reduce the mother to child 
transmission of the virus. Sex education  on the dangers of multiple sexual 
partners or sexual promiscuity, availability of  barrier methods of 
contraception and  patronage, more efforts/interventions by relevant agencies, 
high sense of vigilance amongst others are very vital to curtailing this global 
pandemic in our society. 
Keywords: HIV infection, HIV determinants, seroprevalence, pregnancy 
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Introduction 
 The pandemicity of  the human immunodeficiency virus (HIV) cannot 
be overemphasized as it has continued to be a ‘medical quagmire,’  one of the 
most serious global catastrophe and  public health problem that plagues the  
world today. Acquired immunodeficiency syndrome (AIDS) has killed more 
than 25 million people since its discovery in 1981(UNAIDS, 2006).  The Joint 
United Nations Programme on HIV/AIDS (UNAIDS) estimated that, in 2008, 
approximately 33.4 million people worldwide (1% of the global adult 
population aged 15-49 years) were infected with HIV; 67% of all people living 
with HIV worldwide live in sub-Saharan Africa, and 91% of all new infections 
among children occur there (UNAIDS, 2009).   
 HIV/AIDS continues to strain the struggling health system of many 
developing countries and remains a threat to health in Nigeria as it has 
encumbered and  reversed many developmental gains of the recent past 
including maternal and under-five mortality rates. Currently with an estimated 
population of  193,854,816  (Worldometers, 2017)  and an annual growth rate 
estimated to be 2.63% in 2017 as reported by the United Nations 
(Worldometers, 2017) , Nigeria is the most populated country in sub-Saharan  
Africa and after South Africa, Nigeria has the second largest number of people 
living with HIV in the world. To buttress this, one out of every 11 persons live 
with the virus in the country (NACA, 2011).   
 Nigeria is responsible for 30% of the global burden of mother to child 
transmission (MTCT) of HIV, and is one of the 22 focal countries of  the 
Global Plan to Eliminate MTCT. This is in contrast to the developed countries 
like Australia and the Netherlands where MTCT is 0.23 per 100 and 0.26 per 
100, respectively. (UNAIDS, 2011,  Spencer JD et al, 2003,  Vanderbij AH et 
al, 2003).  
 The first two AIDS cases in Nigeria was diagnosed in 1985 and 
reported in 1986 in Lagos one of which was a young female sex worker aged 
13 years from one of the West African countries.  (Nasidi, A. & Harry, T.O. 
2006). Sequel to this, the Nigerian Government adopted Ante Natal Care 
(ANC) sentinel surveillance as the system for assessing the epidemic. The first 
HIV Sentinel Survey in 1991 showed a prevalence of 1.8%. Subsequent  
surveys  revealed a progressively increasing prevalence of  3.8%  in 1993, 
4.5% in 1996, 5.4% in 1999, 5.8% in 2001 and 5.0% in 2003. In 2005, the 
prevalence declined; 4.4% in 2005, 4.6% in 2008, 4.1 % in 2010(FMH report, 
2010).   and 3.4% in  20I2 (Olokor O, 2013). Even though there was a steady 
decline from 4.6% in 2008 to 3.4% in 2012, it’s still a far cry from the 1.8% 
in 1991. 
 Whereas evidence suggests that pregnancy has little or no effect on 
HIV progression in asymptomatic women or women with early infection. 
However, in symptomatic patients when HIV is more advanced, it results in 
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an increase in certain pregnancy complications such as intrauterine growth 
retardation, preterm birth, and low birth weight. Obstetric and or 
gynaecological factors like early age at first coitus, low parity, a history of 
termination of pregnancy, and hospital delivery were identified as risk factors 
for HIV infection among pregnant women. (Smith NH & Hwang LY. 1996,  
Pettifor AE et al, 2004,  Perry D et al, 2002, Etukumana EA et al, 2011)   
 A public health approach based primarily on information and 
educational programme focussed on ways of preventing HIV acquisition by 
women of the reproductive age group and their partners remains the gold 
standard for tackling the HIV epidemic and its associated problems, 
Secondarily, this includes tackling the unmet needs of contraception among 
HIV positive women and the prevention of mother to child transmission of 
HIV. (Evelyn UI & Osafu O, 1999). 
 
Objectives 
 The general objective is to determine the seroprevalence  and clinico-
epidemiological correlates of HIV infection  in pregnancy in Yenagoa.  
 The specific objectives are (1) To find out the seroprevalence of HIV 
antibodies in pregnant women that present in clinic. (2) To identify known risk 
factors for HIV infection in pregnant women. (3) To make evidence based 




 This study was carried out at the Antenatal clinic of the Federal 
Medical Centre, Yenagoa, Bayelsa state in the South-south region of Nigeria 
between  4th September to 28th October, 2016.  
 
Study design 
A descriptive cross sectional study. 
 
Inclusion criteria 
 This included  all pregnant women who presented for booking at the 
antenatal clinic of FMC Yenagoa and  gave consent. 
 
Exclusion criteria  
• This  included all pregnant women who declined to participate. 
• Patients who withheld their consent for inclusion in the study. 
 
Sample size  
 The sample size was calculated using the statistical formula (Araoye 
MO, 2003)  based on reported prevalence rate of  HIV antibody  of 4.9% 
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(Ibrahim, I. A, et al, 2013) from previous a study and a confidence interval of  
95%.  
 
Study population  
 The minimum sample size was thus calculated to be 86 with an attrition 
of 20%. However, a total of  220 consecutive healthy pregnant women 
attending the antenatal booking clinic of the hospital who met the inclusion 
criteria were recruited into this study after pre test counselling and obtaining 
consent from them. This was tested for antibodies to HIV-1 and HIV-2. 
 
Sample collection and processing 
 Five millilitres (5ml) of peripheral venous blood was collected from 
consecutive subjects in the antenatal booking clinic into plain sterile bottles. 
Blood samples were centrifuged for ten minutes at 6,000 rpm, serum was 
obtained and stored at -200C until used. 
 Samples were analysed in batches with commercially available in vitro 
diagnostic kits (one step test strips). The HIV- 1/2 one step test is a rapid lateral 
flow immunoassay which qualitatively detects the presence of antibodies in 
serum utilizing a combination of monoclonal and polyclonal antibodies to 
HIV-1 and HIV-2. The membrane is percolated with recombinant antigen and 
synthetic peptide on the test line region of the strip. During testing, the serum 
specimen reacts with the particles coated with HIV-1/2 antigen. The mixture 
migrates upward on the membrane chromatographically by capillary action to 
react with antibodies to HIV 1/2 on the membrane and generate a coloured 
line in the test region. Chase buffer is required for whole blood testing. 
 To serve as procedural control, a coloured line always appeared at the 
control line region indicating that proper volume of specimen had been added 
and membrane wicking had occurred. Tests in which two distinct red lines 
appeared, one in the control region and another in the test region, was regarded 
as positive. Tests in which only the control line was distinctly coloured red 
was  recorded as negative while tests in which the control line fails to appear 
was regarded as invalid and was repeated. 
 
Questionnaire 
 Women were enrolled and underwent pretest counselling and were 
administered a structured interviewer- administered questionnaire. 
 
Data analysis 
 Data was analysed using SPSS (statistical package for social sciences) 
22 statistical package (SPSS Inc., Illinois, U.S.A). Univariate analysis for 
categorical variables was performed using chi-square. P value less than 0.05 
was taken as being significant. 
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Ethical considerations 
 Approval for the study was obtained from the ethical committee of the 
Federal Medical Centre, Yenagoa. The study was carefully explained to the 




 A total of two hundred and twenty (220) pregnant women were 
interviewed.  
 The mean age of the pregnant women studied was 28.8 years ± 5.2. 
The predominant age group was 20-29 years (50.0%). Majority (50.0%) of the 
respondents were from the Ijaw ethnic group and it is followed closely by the 
Igbo ethnic group (28.2%). Most (96.8%) of the respondents were Christians.  
Majority (41.8%) of the respondents were involved in doing business as an 
occupation. Majority (91.8%) also of the respondents were married, and most 
of the marriages were of the polygamous type or setting (83.7%). Most 
(77.8%) had a secondary education.  
 Amongst those that agreed that the virus could be transmitted from 
person to person, 15 (51.7 %) said it is through blood/blood products; while 
10 (34.5%) said it is through sexual intercourse; and 2 (6.9%) said it is through 
body fluids- urine, saliva and physical contact with infected persons.  
 Twelve (5.5%) of the respondents said yes, that the virus could be 
transmitted from a mother to her baby, while 206 (94.5%) did not know if 
there could be transmission of the viruses from a mother to her baby. Amongst 
those that said yes, 4 (33.3%) said the infection occurs during delivery; while 
5 (41.7%) do not know how the transmission occurs; 2 (16.7%) said it occurs 
in-utero; and 1 (8.3%) said it occurs during breastfeeding. 
 Majority (72.6%) of the respondents has had more than one sexual 
partner in their life. Most (85.3%) of the respondents did not know if their 
spouses had other sexual partners. Eighty-five point nine percent (85.9%) said 
they have not had sexually transmitted infections in the past; and 94% of the 
respondents has not had transfusion of blood and blood products; 96.8% do 
not share needles/blades with other people; and 98.6% do not inject illicit 
drugs. There is a statistically significant association between respondents with 
more than one sexual partner and Seroprevalence of HIV Infection (X2= 5.59, 
df = 1, P < 0.05). 
Table1: Result of  HIV antibody test amongst respondents. 
Variables                                                                                                                          
Total       
                                                                         Frequency (%)                             
                                                     Reactive                      Non reactive 
Retroviral screening                    10 (4.6)                         210 (95.4)                          220 
(100.0) 
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Four point six percent (4.6%) of the respondents were reactive to HIV 
antibody 
Table 2: The prevalence of HIV antibody amongst the different parity groups. 
Variables                                               Frequency (%)                                                                  
                                                           Retroviral screening                                                                  
                                            Reactive                                                Non reactive                             
Parity  
0 – 1                                     5 (50.0)                                                 117 (55.7)                                                        
2 – 3                                     3 (30.0)                                                  51 (24.3) 
4 – 5                                     0 (0)                                                       25 (11.9) 
6 – 7                                     2 (20.0)                                                  10 (4.8) 
8 – 9                                     0 (0)                                                         7 (3.3)                                                      
Total                                    10 (100.0)                                             210 (100.0) 
 
 Reactivity to the retroviral screening test was highest (50%) amongst 
the 0 -1 parity group; followed closely by the 2 – 3 parity group with 30%; 
and the 6 – 7 parity group with 20% reactivity. The mean parity was 1.20 ± 
1.16. 
Table 3: The prevalence of HIV antibody amongst the different gestational age (GA) 
groups. 
Variables                                               Frequency (%)                                                                  
                                                           Retroviral screening                                                                  
                                            Reactive                          Non reactive                             
GA (In weeks) 
1 – 10                                   1 (10.0)                                                  32 (15.2) 
11 – 20                                 5 (50.0)                                                  73 (34.8) 
21 – 30                                 3 (30.0)                                                  69 (32.9) 
31 – 40                                 1 (10.0)                                                  36 (17.1) 
Total                                    10 (100.0)                                              210 (100.0) 
 
 The prevalence of retroviral disease was 5(50.0%) in those of GA 11 
– 20 weeks; 3 (30.0%) amongst those with GA 21 – 30 weeks; and 1 (10%) 
amongst those with GA 1 – 10, and 31 – 40 weeks. 
Table 4: The relationship between retroviral disease positivity and gestational age (GA). 
Variables                                               Frequency (%)                                                                  
                                                           Retroviral screening                                                                  
                                   Reactive                          Non reactive                       Test/p-value    
GA (In weeks) 
1 – 10                      1 (10.0)                             32 (15.2) 
11 – 20                    5 (50.0)                             73 (34.8)                             x2 = 1.11 
21 – 30                    3 (30.0)                             69 (32.9)                             df = 3 
31 – 40                    1 (10.0)                             36 (17.1)                             p > 0.05 
Total                     10 (100.0)                         210 (100.0) 
 
 From the results of X2 statistics in the table above, gestational age was 
not found to statistically related to higher positivity of retroviral disease. 
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Table 5: Risk factors/transmission mechanisms of retroviral disease. 
Variables                                                                                    Frequency (%)                                    Total 
                                                                                         Yes                 No             I don’t know 
Have you had surgery in the past                                            28 (12.8)         190 (87.2)                                         218 (100.0) 
If yes specify 
Appendectomy                                                                            11 (39.3)          0 (0) 
Caesarean section                                                                        15 (53.6)          0 (0) 
Ectopic surgery                                                                             2 (7.1)             0 (0) 
Total                                                                                           28 (100.0)        0 (0)  
Do you have any tattoos? Scarification marks                        2 (0.9)           213 (99.1)                                        215 (100.0) 
Were you circumcised                                                               24 (10.9)       196 (89.1)                                        220 (100.0) 
Have you procured an abortion by dilatation and curettage 
                                                                                                      18 (8.2)        201 (91.8)                                        219 (100.0) 
 
Have you ever been given episiotomy during delivery             4 (1.8)         216 (98.2)                                        220 (100.0) 
Have you ever had blood /blood product transfusion               13 (6.0)       205 (94.0)                                        218 (100.0) 
illicit(hard) drugs                                                                           3 (1.4)        216 (98.6)                                       219 (100.0) 
 
 Amongst the respondents, 28 (12.8%) has had surgeries in the past; 11 
(39.3%) has had appendectomy; while 15 (53.6%); and 2 (7.1%) has had 
caesarean section and ectopic surgeries respectively.  
 Two (0.9%) of the respondents had tattoo and scarification marks, 
while most 213 (99.1%) had none. Twenty four (10.9%) of the respondents 
were circumcised; while 18 (8.2%) had procured abortion by dilation and 
curettage; 4 (1.8%) has had episiotomy given to them during delivery in the 
past. 
Table 6: The relationship between age, level of educational of respondents and retroviral 
screening positivity. 
Variables                       frequency (%)     Retroviral screening 
                                                                     Reactive (%)                        Test/ p value 
Age as at last birthday in years (N = 220) 
10 – 19                                   9 (4.0)                        1 (10.0)                                 
20 – 29                               110 (50.0)                      4 (40.0)                                        x2 = 1.96 
30 – 39                                 93 (42.3)                      4 (40.0)                                       df = 3 
40 – 49                                  8   (3.6)                       1 (10.0)                                        p > 0.05  
 
Level of education (N = 194) 
None                                     0 (0)                            0 (0) 
Primary                                7 (3.6)                         1 (10.0)                                           x 2 = 1.38 
Secondary                          151 (77.8)                     8 (80.0)                                            df = 3 
Tertiary                               36 (18.6 )                     1 (10.0)                                            p >  0.05 
 
 From the results of X2 statistics in the table above,  age and level of 
education of respondents  were not found to be statistically related to higher 
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Discussion 
 This is a hospital based study to determine the burden of HIV infection 
in our obstetric population looking at the seroprevalence, risk factors and 
clinico-epidemiological correlates of HIV infection  in pregnancy. 
 The seroprevalence of HIV antibodies in our pregnant women 
population was 4.6%. This figure conforms to the Center for Disease Control 
and Prevention (CDC) cut off of  > 1.2% for high risk populations. (CDC, 
2006). and it is similar to the 4.9% that was reported in Niger Delta University 
Teaching Hospital (NDUTH), Okolobiri, Bayelsa state. (Ibrahim, I. A, et al, 
2013). This is not surprising as both hospitals are tertiary health facilities in 
the same state and  share similar sociocultural characteristics. Other similar 
prevalences were found in Cross River (4.4%) and Ondo state(4.3%). (FMH 
report, 2013). According to the Federal Ministry of Health, 2013. National 
HIV & AIDS and Reproductive Health Survey, the prevalence of 4.6% in our 
study was higher than the national prevalence of 3.4%, Abia (3.3%), Osun 
(2.6%), Imo (2.5%), Lagos (2.2%), Enugu (1.3%) and Delta state (0.7%) 
amongst others. It is however lower than figures from Rivers (15.2%), Taraba 
(10.5%), Kaduna (9.2%), Federal Capital Territory (7.5%) and Akwa Ibom 
state (6.5%) to say the least. (FMH report, 2013). 
 
 There seems to be an upward trend of the prevalence of HIV infection 
in Bayelsa state. Prevalence of  2.7% (FMH report, 2013)   in 2012 when 
compared to our study with a prevalence of 4.6%. Poverty, reduced emphasis 
on education, lack of continuous advocacy and increased promiscuity in view 
of the current economic condition in addition to poor funding by relevant 
agencies saddled to undertake the responsibility to curb  the scourge may 
account for the upward trend. This means that more efforts/interventions 
should be geared towards halting, reducing or reversing this alarming rate. 
 In this study, the seroprevalence of HIV antibody was found to be 
highest amongst the 20 – 29 and 30-39 age group with 40.0% seroprevalence 
each. There was a fall with an abrupt decline afterwards. This was supported 
by the 2010 HIV survey in Nigeria (NACA, 2014) where the infection is more 
prevalent among the 20-39 year age group. Similar findings of 25-29 years age 
group were reported in the Uyo (Nyoyoko  N. P. &  Umoh A.V, 2016), Nnewi 
(Umeononihu OS et al, 2013) and Tanzanian (Msuya SE et al, 2006) studies. 
However, in Harare, Zimbabwe (Mbizvo MT et al, 2001) women aged 17 
years and below had the highest  incidence (6.25%) followed by those aged 18 
-19 years (5.42%). From the above, one may not be wrong to say that the HIV 
infection in women occur at a younger age, during the first few years after 
sexual debut. This also is in keeping with previous studies which reveals that 
women in their sexually active years and at the peak of their child bearing 
years are the most affected as the major route of transmission of the virus is 
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through heterosexual intercourse in our environment. (Ekure EN & Etuk SJ, 
2001, Duru MU et al, 2009). However, there was no statistical significance 
between age and HIV antibody seropositivity in this study (p > 0.05). 
 Educational status, occupation, parity and age at last birthday were not 
identified as risk factors of HIV infection in this study; this is in contrast with 
other studies performed in similar institutions which revealed these as risk 
factors of HIV infection. (Duru MU et al, 2009, Smith NH & Hwang LY, 
1996).  Majority (50.0%) of the women  were from the Ijaw ethnic group and 
it is followed closely by the Igbo ethnic group (28.2%). Most (96.8%) were 
Christians.  Majority (41.8%)  were involved in doing business as an 
occupation. Majority (91.8%) also were married, and most of the marriages 
were of the polygamous type or setting (83.7%). Most (77.8%) had a 
secondary education. Being the only urban tertiary facility serving as a referral 
center to the people of Bayelsa state and its environs, it’s thus open and 
accessible to all calibers of patients. This may explain the differences above. 
 There was a statistically significant association between women with 
more than one sexual partner and seroprevalence of HIV Infection (X2= 5.59, 
df = 1, P < 0.05). Majority (72.5%) of the obstetric women have had a history 
of multiple sexual partners in their life and in addition, most (85.3%) of them 
did not know if their spouses had other sexual partners. Ibrahim, I. A. et al 
reported similar finding in NDUTH, Okolobiri, Bayelsa state. (Ibrahim, I. A, 
et al, 2013) 
 Amongst the women, 28 (12.8%) have had surgeries in the past; 11 
(39.3%)  had appendectomy; while 15 (53.6%); and 2 (7.1%) have  had 
caesarean section and ectopic surgeries respectively.  
 Tattoo and scarification marks (0.9%), circumcision (10.9%), abortion 
by dilation and curettage (8.2%), surgeries (12.8%), blood transfusion (6.0%) 
and illicit drug (1.4%) use were not identified as risk factors to HIV 
seropositivity in this study. Possible explainations are; The cultural practice in 
this environment is on the decline, as such it is not a surprising occurrence; 
Concerning abortion, it could be because most of the D and C was done in the 
hospital and the instruments used could have been well sterilized; This may 
have been due to the aversion to receiving blood among our people; In Nigeria, 
illicit (hard) drugs including narcotics are strictly under control and attract 
severe sanctions thus limiting availability and or accessibility. 
 
Conclusion 
 The high endemicity of HIV  infection in this study according to Center 
for Disease Control and Prevention, justifies the need for routine screening in 
pregnancy to identify and institute treatment of the infection promptly as this 
will reduce the mother to child transmission of the virus. Sex education on the 
dangers of multiple sexual partners or sexual promiscuity, availability of 
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barrier methods of contraception and patronage, more efforts/interventions by 
relevant agencies, high sense of vigilance  amongst others are very vital to 
curtailing this global pandemic in our society. 
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